
Tenvir 300mg Tablet
Salt Composition: Tenofovir Disoproxil Fumarate
Expiry Date: 01/2028
Inclusive of all taxes
30 tablet
About The Product
- Chronic Hepatitis B (HBV)
- HIV-1 Treatment
- HIV Prophylaxis (PrEP)
- Chronic hepatitis B virus (HBV) infection is treated with Tenvir Tablet which contains Tenofovir Disoproxil Fumarate.
- Along with other anti-HIV medications, it is also used to treat HIV infection. It stops viruses from growing inside human cells. This removes your infection and prevents the virus from producing new ones.
- Tenvir Tablet only helps to lower the level of HIV in your body; it is not a treatment for HIV/AIDS. This extends your life expectancy and reduces your chance of developing HIV-related problems.
- In certain high-risk individuals, Tenofovir Disoproxil Fumarate may also be used to prevent HIV infection. Adults and adolescents between the ages of 12 and 18 can use this tablet.
Uses
- Chronic Hepatitis B (HBV)
- HIV-1 Treatment
- HIV Prophylaxis (PrEP)
Side Effects
The following are the possible side effects that can occur during your treatment with Tenvir Tablet. Contact your medical practitioner immediately if any of the above-mentioned side effects appear.
- Fatigue
- Cough
- Diarrhea
- Nausea
- Rash
- Vomiting
- Fatigue
- Increased transaminase levels in the blood
- Decreased phosphate level in blood
- Abdominal Pain
- Depression
- Insomnia (difficulty in sleeping)
- Fever
- Dizziness
How To Use
- Take this medicine exactly as prescribed by your doctor, for the recommended dose and duration.
- Swallow the whole tablet; do not chew, crush, or break it.
- Tenvir Tablet can be taken with or without food.
How It Works
- It functions as a nucleotide reverse transcriptase inhibitor (NRTI) by blocking the enzymes hepatitis B DNA polymerase and HIV reverse transcriptase, which are critical for virus replication. HIV RNA is converted into DNA by the reverse transcriptase enzyme.
- A nucleotide analog called tab tenvir 300 mg prevents DNA synthesis by inhibiting the reverse transcriptase enzyme. It boosts CD4 (T) cells and lowers the blood's HIV viral load, allowing the immune system to fight off other infections.
- This reduces the possibility that a weakened immune system will become severely compromised and result in mortality.
Safety Advice
Missed Doses
If you miss a scheduled dose of Tenvir tablets, contact your doctor immediately.
FAQs
Tenvir tablet is an antiviral medication that prevents the human immunodeficiency virus (HIV) from multiplying in your body.
It also helps to delay the production of HIV infection and improves the quality of life.
References
- Abe, K., Imamura, J., Sasaki, A., et al. (2024). Renal function and lipid metabolism in Japanese HIV‑1-positive individuals 288 weeks after switching from TDF to TAF: A single-center, retrospective cohort study. Journal of Pharmaceutical Health Care and Sciences, 10, 13. https://pubmed.ncbi.nlm.nih.gov/38419093/
- Agbaji, O., et al. (2018). Incidence and predictors of tenofovir disoproxil fumarate‑induced renal impairment in HIV‑infected Nigerian patients. BMC Nephrology, 19, 206. https://pubmed.ncbi.nlm.nih.gov/29951379/
- Baeten, J. M., et al. (2017). Liver and renal safety of tenofovir disoproxil fumarate in combination with emtricitabine among African women in a pre‑exposure prophylaxis trial. BMC Pharmacology and Toxicology, 18, 77. https://pubmed.ncbi.nlm.nih.gov/25539648/
- Cooper, R. D., Wiebe, N., Smith, N., Keiser, P., Naicker, S., & Tonelli, M. (2025). Systematic review and meta‑analysis: renal safety of tenofovir disoproxil fumarate in HIV‑infected patients. Clinical Infectious Diseases, 51(5), 496–505. https://pubmed.ncbi.nlm.nih.gov/20673002/
- Fletcher, C. V., et al. (2023). Renal safety of long‑term tenofovir disoproxil fumarate treatment in patients with chronic hepatitis B. Journal of Hepatology, 79(3), 640–648. https://pubmed.ncbi.nlm.nih.gov/37614515/
- Yuan, Y., et al. (2024). Effects of prolonged administration of tenofovir disoproxil fumarate‑containing antiviral regimen on renal function in low‑risk kidney injury HIV patients. The Journal of Clinical Pharmacology. https://pubmed.ncbi.nlm.nih.gov/38323669/
- Zhao, J., Wu, L., Yang, X., Gao, Z., & Deng, H. (2024). Renal function changes in chronic hepatitis B patients. arXiv preprint.
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.
